Literature DB >> 12654316

Use of phage display and high-density screening for the isolation of an antibody against the 51-kDa subunit of complex I.

John L Rubinstein1, Lucy J Holt, John E Walker, Ian M Tomlinson.   

Abstract

Monoclonal antibodies play an increasingly important role in structural biology. In this report, we develop the use of phage display technology for the isolation of an antibody that binds to a specific subunit of a macromolecular assembly. Antibodies that bind to the intact complex are selected from a phage display library and screened with a high-density Western blot to identify a subunit-specific binder. Conventional Western blotting and competition ELISA are then used to confirm the identity of the target subunit and that the antibody binds to the native protein complex and not to an epitope that is only revealed when the antibody is immobilized for phage selection. Using this technique, monoclonal scFv and Fab fragments have been produced that bind to the 51-kDa subunit of bovine complex I, a large integral membrane protein complex from mitochondria.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654316     DOI: 10.1016/s0003-2697(02)00649-8

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  3 in total

1.  A fast and efficient procedure to produce scFvs specific for large macromolecular complexes.

Authors:  Si Wu; Ailong Ke; Jennifer A Doudna
Journal:  J Immunol Methods       Date:  2006-11-03       Impact factor: 2.303

2.  Selective recognition of a DNA G-quadruplex by an engineered antibody.

Authors:  Himesh Fernando; Raphaël Rodriguez; Shankar Balasubramanian
Journal:  Biochemistry       Date:  2008-08-15       Impact factor: 3.162

3.  Tuning the drug efflux activity of an ABC transporter in vivo by in vitro selected DARPin binders.

Authors:  Markus A Seeger; Anshumali Mittal; Saroj Velamakanni; Michael Hohl; Stefan Schauer; Ihsene Salaa; Markus G Grütter; Hendrik W van Veen
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.